MiRagen rebrands to Veridian months after acquisition, names new CEO
BOULDER — Biopharmaceutical maker miRagen Therapeutics Inc. (Nasdaq: MGEN) has made its biggest moves yet after a tumultuous several months, […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
A new Foothills — again
FORT COLLINS — The new owners who want to revitalize midtown Fort Collins’ half-century-old Foothills mall say they envision “a…
Biotechnology boom
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
New hangar report encourages displaced aircraft owners
LOVELAND – The findings of a new and more positive structural study of two previously condemned general-aviation hangar buildings at…
MiRagen says it has cash to last through late 2021
BOULDER — Cancer-drug developer MiRagen Therapeutics Inc. (Nasdaq: MGEN) posted a multi-million dollar loss in the last quarter but expects…